Novocure to Report To start with Quarter 2021 Economic Effects | Business enterprise & Finance

ST. HELIER, Jersey–(Organization WIRE)–Apr 1, 2021–

Novocure (NASDAQ: NVCR) announced these days that it will report financial final results for the 1st quarter 2021 on Thursday, April 29, 2021, just before the U.S. economical markets open. Novocure’s administration will host a conference call and webcast to explore its money success for the 3 months ended March 31, 2021, at 8 a.m. EDT on Thursday, April 29, 2021. Analysts and traders can take part in the meeting simply call by dialing 855-442-6895 for domestic callers and 509-960-9037 for worldwide callers, utilizing the conference ID 2286525.

The webcast, earnings slides offered throughout the webcast and the company presentation can be accessed reside from the Investor Relations page of Novocure’s web site, www.novocure.com/investor-relations, and will be readily available for at minimum 14 days adhering to the phone. Novocure has employed, and intends to proceed to use, its investor relations site, as a suggests of disclosing material non-public details and for complying with its disclosure obligations beneath Regulation FD.

Novocure is a international oncology corporation working to prolong survival in some of the most intense forms of most cancers by the progress and commercialization of its ground breaking treatment, Tumor Managing Fields. Tumor Managing Fields is a most cancers therapy that employs electric powered fields to disrupt most cancers cell division. Novocure’s commercialized products and solutions are approved for the treatment of grownup sufferers with glioblastoma and malignant pleural mesothelioma. Novocure has ongoing or done scientific trials investigating Tumor Managing Fields in mind metastases, non-small cell lung cancer, pancreatic cancer, ovarian most cancers, liver cancer, gastric cancer and glioblastoma.

Headquartered in Jersey, Novocure has U.S. functions in Portsmouth, New Hampshire, Malvern, Pennsylvania and New York Town. Additionally, the company has places of work in Germany, Switzerland, Japan and Israel. For more data about the organization, make sure you pay a visit to www.novocure.com or observe us at www.twitter.com/novocure.

Ahead-Wanting Statements

In addition to historical specifics or statements of existing ailment, this push release may well incorporate forward-hunting statements. Ahead-seeking statements give Novocure’s present-day anticipations or forecasts of long run activities. These may perhaps consist of statements concerning expected scientific development on its study plans, scientific demo progress, development of possible products, interpretation of medical effects, prospects for regulatory acceptance, production improvement and abilities, sector potential clients for its solutions, coverage, collections from 3rd-get together payers and other statements with regards to issues that are not historic facts. You may possibly detect some of these ahead-searching statements by the use of phrases in the statements this sort of as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” or other text and terms of identical indicating. Novocure’s efficiency and financial final results could differ materially from all those mirrored in these forward-searching statements because of to standard financial, economic, environmental, regulatory and political disorders as well as troubles arising from the COVID-19 pandemic and other far more certain threats and uncertainties experiencing Novocure these as these established forth in its Annual Report on Variety 10-K submitted on February 25, 2021 with the U.S. Securities and Trade Fee. Presented these hazards and uncertainties, any or all of these forward-seeking statements may well verify to be incorrect. Consequently, you must not rely on any these kinds of elements or ahead-seeking statements. Moreover, Novocure does not intend to update publicly any forward-seeking assertion, apart from as demanded by law. Any forward-on the lookout statements herein converse only as of the date hereof. The Private Securities Litigation Reform Act of 1995 permits this dialogue.

Field Keyword: BIOTECHNOLOGY Clinical Units Health and fitness RADIOLOGY ONCOLOGY

Copyright Company Wire 2021.

PUB: 04/01/2021 06:00 AM/DISC: 04/01/2021 06:01 AM

Copyright Business enterprise Wire 2021.